Profund Advisors’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Sell |
22,357
-4,967
| -18% | -$28.7K | ﹤0.01% | 950 |
|
|
2025
Q1 | $180K | Sell |
27,324
-1,034
| -4% | -$6.82K | 0.01% | 918 |
|
|
2024
Q4 | $247K | Buy |
28,358
+9,490
| +50% | +$82.7K | 0.01% | 874 |
|
|
2024
Q3 | $369K | Sell |
18,868
-4,699
| -20% | -$91.8K | 0.01% | 685 |
|
|
2024
Q2 | $485K | Sell |
23,567
-25,115
| -52% | -$517K | 0.02% | 507 |
|
|
2024
Q1 | $1.04M | Buy |
48,682
+23,094
| +90% | +$493K | 0.04% | 349 |
|
|
2023
Q4 | $368K | Sell |
25,588
-14,033
| -35% | -$202K | 0.02% | 676 |
|
|
2023
Q3 | $361K | Buy |
39,621
+3,228
| +9% | +$29.4K | 0.02% | 573 |
|
|
2023
Q2 | $385K | Sell |
36,393
-14,779
| -29% | -$156K | 0.02% | 593 |
|
|
2023
Q1 | $626K | Buy |
+51,172
| New | +$626K | 0.04% | 437 |
|